The efficacy of reconstructive therapy in the surgical management of peri‐implantitis: A 3‐year follow‐up of a randomized clinical trial
Journal of Clinical Periodontology · 2024
DOI: 10.1111/jcpe.14049 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Periodontology, 2024. Verfasst von Stefan Renvert und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oral Health Sciences, Kristianstad University, Kristianstad, Sweden. Hauptthemen laut MEDLINE: Peri-Implantitis, Guided Tissue Regeneration, Periodontal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Geistlich Pharma AG, Switzerland, Research Foundation at Kristianstad University, Sweden, Geistlich Pharma.
Abstract (Originalsprache)
Aim
To assess whether guided bone regeneration (GBR) treatment of peri‐implantitis‐related bony defects could improve healing compared to open flap debridement (OFD) at 36 months. Materials and Methods In a multi‐centre, randomized clinical trial, 32 individuals received OFD (control group [CG]) and 34 GBR treatment (test group [TG]). Radiographic defect fill (RDF), probing pocket depth (PPD), bleeding on probing (BOP) suppuration (SUP), mucosal recession (MREC) and patient‐reported outcomes (PROs) were evaluated at 36 months.
Results
Fifty individuals attended a supportive peri‐implant therapy program and completed the 36‐month follow‐up. GBR treatment resulted in an RDF of 2.13 ± 1.26 mm compared to 1.64 ± 1.54 mm following OFD ( p = .18). No difference was found in PPD, BOP, SUP, REC or PROs between the groups. Successful treatment (no additional bone loss, PPD ≤ 5 mm, no BOP and no SUP) was achieved in 46.2% in TG and 20% in CG ( p = .053). Treatment results obtained at 12 months were generally maintained up to 36 months. No significant changes were noticed between 12 and 36 months.
Conclusions
At 36 months, treatment results obtained at 1 year were sustained following both GBR and OFD in patients attending supportive peri‐implant therapy. GBR resulted in more RDF and higher composite treatment success rate than OFD ( ClinicalTrials.gov Identifier [NCT02375750]).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oral Health Sciences, Kristianstad University, Kristianstad, Sweden.
- Department of Health, Blekinge Institute of Technology, Karlskrona, Sweden.
- Division of Restorative Dentistry & Periodontology, Dublin Dental University Hospital, Trinity College Dublin, Dublin, Ireland.
- Institute of Health, University of Corsica, Corte, France.
- Private Practice, Hanau, Germany.
- Department of Prosthodontics, University Medical Center, Goettingen, Germany.
ORCID-Profile: Stefan Renvert
Förderung
- Geistlich Pharma AG, Switzerland
- Research Foundation at Kristianstad University, Sweden
- Geistlich Pharma
Zitieren
APA
Renvert, S., Giovannoli, J. L., & Rinke, S. (2024). The efficacy of reconstructive therapy in the surgical management of peri‐implantitis: A 3‐year follow‐up of a randomized clinical trial. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.14049
Vancouver
Renvert S, Giovannoli JL, Rinke S. The efficacy of reconstructive therapy in the surgical management of peri‐implantitis: A 3‐year follow‐up of a randomized clinical trial. Journal of Clinical Periodontology. 2024. doi:10.1111/jcpe.14049
BibTeX
@article{Renvert2024,
author = {Renvert, Stefan and Giovannoli, Jean-Louis and Rinke, Sven},
title = {The efficacy of reconstructive therapy in the surgical management of peri‐implantitis: A 3‐year follow‐up of a randomized clinical trial},
journal = {Journal of Clinical Periodontology},
year = {2024},
doi = {10.1111/jcpe.14049}
}
EUVIMED